Production of IL-1β and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis

被引:101
作者
de Jong, BA
Huizinga, TWJ
Bollen, ELEM
Uitdehaag, BMJ
Bosma, GPT
van Buchem, MA
Remarque, EJ
Burgmans, ACS
Kalkers, NF
Polman, CH
Westendorp, RGJ
机构
[1] Leiden Univ, Ctr Med, Dept Internal Med, NL-2300 RC Leiden, Netherlands
[2] LUMC, Dept Clin Epidemiol, Leiden, Netherlands
[3] LUMC, Dept Rheumatol, Leiden, Netherlands
[4] LUMC, Dept Neurol, Leiden, Netherlands
[5] VU Med Ctr, Dept Neurol, Amsterdam, Netherlands
[6] LUMC, Dept Radiol, Leiden, Netherlands
[7] LUMC, Dept Gerontol, Leiden, Netherlands
[8] VU Med Ctr, MS MRI Ctr, Amsterdam, Netherlands
关键词
multiple sclerosis; immunogenetics; interleukin-1; polymorphisms; magnetization transfer ratio histogram analysis;
D O I
10.1016/S0165-5728(02)00056-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-1beta (IL-1beta) is present in multiple sclerosis (MS) lesions. Interleukin-1 receptor antagonist (IL-1Ra) moderates the induction of experimental autoimmune encephalomyelitis (EAE). Here, we show that families that are characterized by high over IL-1Ra production ratio are at 2.2-fold (95% CI, 1.0-4.8; p = 0.05) increased risk to have a patient relative with relapse-onset MS than families with a low ratio. It is also related to the reduction of volumetric magnetization transfer ratio (MTR) histogram height, a measure of parenchymal integrity (p = 0.04). Those families who combine a high IL-1beta over IL-1Ra ratio with a high tumor necrosis factor (TNF) over IL-10 production ratio have a 6.2-fold (95% CI, 1.8-21; p = 0.002) increased risk. Innate production of IL-1beta and IL-1Ra is not related to the outcome of primary progressive MS. Taq1 polymorphism in the IL-1beta gene and the variable number of tandem repeats (VNTR) polymorphism of 86-base pairs within the IL-1Ra gene cannot explain these findings. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 52 条
[1]   The interleukin-1 system: Receptors, ligands, and ICE in the brain and their involvement in the fever response [J].
Alheim, K ;
Bartfai, T .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :51-58
[2]   Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells [J].
Badovinac, V ;
Mostarica-Stojkovic, M ;
Dinarello, CA ;
Stosic-Grujicic, S .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (01) :87-95
[3]  
Brochet B, 1999, NEUROLOGY, V53, pS12
[4]   THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS [J].
CANNELLA, B ;
RAINE, CS .
ANNALS OF NEUROLOGY, 1995, 37 (04) :424-435
[5]   Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10 [J].
Corsini, E ;
Dufour, A ;
Ciusani, E ;
Gelati, M ;
Frigerio, S ;
Gritti, A ;
Cajola, L ;
Mancardi, GL ;
Massa, G ;
Salmaggi, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 44 (05) :506-511
[6]  
CUNNINGHAM ET, 1993, IMMUNOL TODAY, V14, P171
[7]  
de Jong BA, 2000, ANN NEUROL, V48, P641, DOI 10.1002/1531-8249(200010)48:4<641::AID-ANA11>3.0.CO
[8]  
2-Z
[9]   DIRECT STIMULATION OF CYTOKINES (IL-1-BETA, TNF-ALPHA, IL-6, IL-2, IFN-GAMMA AND GM-CSF) IN WHOLE-BLOOD .1. COMPARISON WITH ISOLATED PBMC STIMULATION [J].
DEGROOTE, D ;
ZANGERLE, PF ;
GEVAERT, Y ;
FASSOTTE, MF ;
BEGUIN, Y ;
NOIZATPIRENNE, F ;
PIRENNE, J ;
GATHY, R ;
LOPEZ, M ;
DEHART, I ;
IGOT, D ;
BAUDRIHAYE, M ;
DELACROIX, D ;
FRANCHIMONT, P .
CYTOKINE, 1992, 4 (03) :239-248
[10]   The effect of interferon beta-1 beta on lymphocyte endothelial cell adhesion [J].
DhibJalbut, S ;
Jiang, H ;
Williams, GJ .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) :215-222